Eli Lilly total assets 2013-2018

Eli Lilly's total assets from 2013 to 2018 (in million U.S. dollars)

by Matej Mikulic, last edited Feb 22, 2019
Eli Lilly total assets 2013-2018 The timeline shows Eli Lilly's total assets from 2013 to 2018. In 2015, the company's total assets amounted to nearly 36 billion U.S. dollars. Eli Lilly is one of the global leading pharmaceutical companies and the world's largest manufacturer and distributor of psychiatric medications.
Show more

Eli Lilly's total assets from 2013 to 2018 (in million U.S. dollars)

You need to log in to download this statistic
Register for free
Already a member?
Log in
Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
Eli Lilly
Eli Lilly

All Information
in one Presentation

Eli Lilly

Everything On "Eli Lilly" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Eli Lilly"
  • Global positioning
  • Revenue and income
  • Expenses
  • Miscellaneous
The most important statistics
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.